Global sentiment received a boost on Tuesday, after the U.S. consumer price index rose just 0.2% in July, an annual increase ...

Investing.com -- ProFrac Holding Corp (NASDAQ:ACDC) stock plunged 32% after the company announced the pricing of its public offering of Class A common stock at $4.00 per share, a significant discount ...

Sapiens International Corporation N.V. (NASDAQ:SPNS) stock surged over 40% to $43.50 on Wednesday after the company announced it has entered into a definitive agreement to be acquired by private ...

By the time the plan is complete, Louisville, Kentucky-headquartered GE Appliances said it will have invested $6.5 billion across its U.S. manufacturing plants and distribution network since it was ...

In theory, a rate reduction could spur investment and spending in the United States. Canada, which sends roughly three-fourths of its exports to its southern neighbor, much of which are exempted from ...

Investing.com -- Renk, a tank gearbox manufacturer, plans to relocate production of items sold to Israel if Germany implements an export embargo on weapons to the country, CEO Alexander Sagel ...

Despite core inflation marking its biggest jump since the start of the year, investors factored in recent weakness in the job market and a shake-up at the Federal Reserve as they leaned in favor of a ...

Gross Merchandise Value (GMV) reached $1.45 billion in Q2, up 34% YoY. The company’s adjusted EBITDA rose to $38.5 million from $31.3 million in the year-ago quarter.

The company has appointed Ingrid Nordlund as interim CEO to lead Hedera Group AB following Sandström’s departure. The management change was disclosed by the Swedish company on Wednesday, though no ...

Bitcoin’s upward momentum faces a pause as sellers defend the $123,000 historical peak, creating the potential for a double top. Buyers are holding the short-term uptrend line, but a breakdown could ...

Investing.com-- Asian stock markets climbed on Wednesday in broad-based buying, tracking sharp overnight gains on Wall Street ...

The brokerage said AbbVie faces no significant loss of exclusivity until the end of the decade, with its next major hit ...